» Articles » PMID: 27356115

Obesity: Definition, Comorbidities, Causes, and Burden

Overview
Journal Am J Manag Care
Specialty Health Services
Date 2016 Jun 30
PMID 27356115
Citations 413
Authors
Affiliations
Soon will be listed here.
Abstract

Body mass index of 30 kg/m2 or higher is used to identify individuals with obesity. In the last 3 decades, the worldwide prevalence of obesity has increased 27.5% for adults and 47.1% for children. Obesity is the result of complex relationships between genetic, socioeconomic, and cultural influences. Consumption patterns, urban development, and lifestyle habits influence the prevalence of obesity. The condition may be the result of disease or pharmacologic treatment. It may also be a risk factor for the development of comorbid conditions. Persons who are obese have less school attendance, reduced earning potential, and higher healthcare costs that may result in an economic burden on society. A review of the prevalence and economic consequences of obesity is provided. Potential causes and comorbidities associated with obesity are also discussed.

Citing Articles

Special Issue "Adipose Tissue Diseases: Physiopathology, Molecular Mechanism, Diagnosis, and Treatment".

Cannataro R, Michelini S, Cione E Int J Mol Sci. 2025; 26(5).

PMID: 40076692 PMC: 11900491. DOI: 10.3390/ijms26052068.


Unraveling molecular interconnections and identifying potential therapeutic targets of significance in obesity-cancer link.

Abdulla A, Sadida H, Jerobin J, Elfaki I, Mir R, Mirza S J Natl Cancer Cent. 2025; 5(1):8-27.

PMID: 40040878 PMC: 11873641. DOI: 10.1016/j.jncc.2024.11.001.


Gender differences in the relationship between cardiometabolic index and all-cause and specific mortality in the United States adults: a national study.

Li T, Zhou H, Zhou H Front Endocrinol (Lausanne). 2025; 16:1525815.

PMID: 40034232 PMC: 11872713. DOI: 10.3389/fendo.2025.1525815.


Flavonoids as Potential Modulators of Pancreatic Lipase Catalytic Activity.

Rocha S, Proenca C, Araujo A, Freitas M, Rufino I, Aniceto N Pharmaceutics. 2025; 17(2).

PMID: 40006530 PMC: 11859905. DOI: 10.3390/pharmaceutics17020163.


Global Perspectives on Obesity and Being Overweight: A Bibliometric Analysis in Relation to Sustainable Development Goals.

Ueda Yamaguchi N, de Almeida L, Carvalho Gomes Correa R, Grossi Milani R, Ueda Yamaguchi M Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003372 PMC: 11855184. DOI: 10.3390/ijerph22020146.